Traferox Technologies, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval ...
Ex vivo renal artery reconstruction is an extensive procedure used to treat complex aneurysms of the artery that supplies your kidney. It involves removing your kidney, repairing the artery, and ...
Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for ...
OneLegacy, the nonprofit organ procurement organization serving Southern California, announced the launch of the first in-house Ex Vivo Lung Perfusion (EVLP) program at an organ procurement ...
Demand for specialised preclinical research equipment is accelerating globally, with cardiovascular instrumentation among the fastest-growing segments. According to Research and Markets, the ...
If Editas Medicine’s CRISPR gene-editing therapy for rare blood diseases reaches the market, it will be in the hands of a different company. The biotech on Tuesday announced plans to partner or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results